Cardiovascular Involvement in COVID-19: A Clinical Review

20 to 35% of patients who died from COVID-19 had preexisting cardiovascular disease, according to a review by Isadora Salvador Rocco. The paper discusses the influence of SARS-CoV-2 infection on the cardiovascular system and hemodynamics, particularly during mechanical ventilation. It analyzes mechanisms like ACE2 binding and coagulation disorders, appealing for closer attention to microhemodynamic monitoring.

Use Cases

• Literature review on COVID-19 and cardiovascular disease based on the analysis of patient mortality statistics.
• Studying the role of ACE2 in SARS-CoV-2 infection and cardiovascular modulation as described in the review.
• Investigating coagulation disorders in COVID-19 based on mentions of D-dimer and prothrombin time levels.
• Analyzing clinical management strategies for mechanical ventilation in COVID-19 patients with cardiovascular involvement.

Strengths

• Provides a specific mortality statistic: 20 to 35% of deceased COVID-19 patients had preexisting cardiovascular disease.
• Focuses on a clinically significant intersection of two major health concerns: COVID-19 and cardiovascular disease.

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

paperswithcode

Collection Method

Likely a literature review or meta-analysis of clinical findings.

Time Range

Focuses on the COVID-19 pandemic beginning in December 2019.